IGFBP3 and chronic kidney disease: We do not recommend assessment of IGF binding protein 3 (IGFBP3) serum concentrations in patients with CKD because low-molecular-mass immunoreactive IGFBP3 fragments accumulate in CKD30 and thus most commercially available IGFBP3 assays deliver falsely elevated IGFBP3 serum levels.